home.aspx

 
.

REGULATORY STRATEGIES FOR THE ANALYTICAL DEVELOPMENT OF NEW BIOLOGICAL ENTITIES AND BIOSIMILARS

SHARESHARESHARE
The webinar will focus on the relationship between analytics of biotherapeutic products and the interpretation of data to build and support a solid regulatory Chemistry, Manufacturing and Control (CMC) strategy. The importance of data interpretation is illustrated in the development of biosimilars and new biological entities, as well as in regulatory specifications regarding biotherapeutic products.